Pharmacy Website
Clinic Website

Intelligence » Multiple Sclerosis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

NDA for Novel Relapsing Multiple Sclerosis Oral Treatment Submitted

Monday, December 17, 2018 -- Alkermes has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for a novel oral fumarate in development to treat relapsing forms of multiple sclerosis (MS).